首页> 外文OA文献 >Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes
【2h】

Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes

机译:激肽B1受体:关键的G蛋白偶联受体及其在炎症和疼痛过程中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Kinins are a family of peptides implicated in several pathophysiological events. Most of their effects are likely mediated by the activation of two G-protein-coupled receptors: B1 and B2. Whereas B2 receptors are constitutive entities, B1 receptors behave as key inducible molecules that may be upregulated under some special circumstances. In this context, several recent reports have investigated the importance of B1 receptor activation in certain disease models. Furthermore, research on B1 receptors in the last years has been mainly focused in determining the mechanisms and pathways involved in the process of induction. This was essentially favoured by the advances obtained in molecular biology studies, as well as in the design of selective and stable peptide and nonpeptide kinin B1 receptor antagonists. Likewise, development of kinin B1 receptor knockout mice greatly helped to extend the evidence about the relevance of B1 receptors during pathological states. In the present review, we attempted to remark the main advances achieved in the last 5 years about the participation of kinin B1 receptors in painful and inflammatory disorders. We have also aimed to point out some groups of chronic diseases, such as diabetes, arthritis, cancer or neuropathic pain, in which the strategic development of nonpeptidic oral-available and selective B1 receptor antagonists could have a potential relevant therapeutic interest.
机译:激肽是涉及多种病理生理事件的肽家族。它们的大多数作用可能是由两个G蛋白偶联受体B1和B2的激活介导的。 B2受体是组成性实体,而B1受体则作为关键的诱导分子,在某些特殊情况下可能会被上调。在这种情况下,最近的一些报道已经研究了B1受体激活在某些疾病模型中的重要性。此外,近年来对B1受体的研究主要集中在确定诱导过程中涉及的机制和途径。分子生物学研究以及选择性和稳定的肽和非肽激肽B1受体拮抗剂的设计在本质上受到了进步的支持。同样,激肽B1受体敲除小鼠的发展极大地帮助扩展了病理状态下B1受体相关性的证据。在本综述中,我们试图说明过去5年中激肽B1受体参与疼痛和炎症性疾病取得的主要进展。我们还旨在指出一些慢性疾病,例如糖尿病,关节炎,癌症或神经性疼痛,其中非肽类口服可用选择性B1受体拮抗剂的战略开发可能具有潜在的相关治疗意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号